Skip to main content


Figure 5 | Radiation Oncology

Figure 5

From: Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma

Figure 5

(a) Immunofluorescence detection of pADPr in GBM cells exposed to 20 mM H 2 O 2 with or without 5 μM ABT-888; scale bar at bottom right = 10 μm. (b) Fluorescence intensity quantification of the pADPr signal estimated using ImageJ (v1.44p, National Institutes of Health, Bethesda, US). Error bars indicate the standard error among 100 cell nuclei.

Back to article page